CDK1 and glioblastoma: Prolonged overall survival in GBM patients had an inversely proportional relationship with the high expression of CDK1, PBK, and CHEK1 at a p-value < 0.05 on the KM graphs, validating the potential prognostic value of the three genes in GBM.